These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 29989169)
1. Real-time optical manipulation of cardiac conduction in intact hearts. Scardigli M; Müllenbroich C; Margoni E; Cannazzaro S; Crocini C; Ferrantini C; Coppini R; Yan P; Loew LM; Campione M; Bocchi L; Giulietti D; Cerbai E; Poggesi C; Bub G; Pavone FS; Sacconi L J Physiol; 2018 Sep; 596(17):3841-3858. PubMed ID: 29989169 [TBL] [Abstract][Full Text] [Related]
2. A Software Architecture to Mimic a Ventricular Tachycardia in Intact Murine Hearts by Means of an All-Optical Platform. Giardini F; Biasci V; Scardigli M; Pavone FS; Bub G; Sacconi L Methods Protoc; 2019 Jan; 2(1):. PubMed ID: 31164591 [TBL] [Abstract][Full Text] [Related]
3. Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. Crocini C; Ferrantini C; Coppini R; Scardigli M; Yan P; Loew LM; Smith G; Cerbai E; Poggesi C; Pavone FS; Sacconi L Sci Rep; 2016 Oct; 6():35628. PubMed ID: 27748433 [TBL] [Abstract][Full Text] [Related]
4. Optical mapping system with real-time control capability. Iravanian S; Christini DJ Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2605-11. PubMed ID: 17644571 [TBL] [Abstract][Full Text] [Related]
5. Optogenetic manipulation of anatomical re-entry by light-guided generation of a reversible local conduction block. Watanabe M; Feola I; Majumder R; Jangsangthong W; Teplenin AS; Ypey DL; Schalij MJ; Zeppenfeld K; de Vries AA; Pijnappels DA Cardiovasc Res; 2017 Mar; 113(3):354-366. PubMed ID: 28395022 [TBL] [Abstract][Full Text] [Related]
6. Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models. Boyle PM; Murphy MJ; Karathanos TV; Zahid S; Blake RC; Trayanova NA J Physiol; 2018 Jan; 596(2):181-196. PubMed ID: 29193078 [TBL] [Abstract][Full Text] [Related]
7. Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach. Karathanos TV; Boyle PM; Trayanova NA Europace; 2014 Nov; 16 Suppl 4(Suppl 4):iv69-iv76. PubMed ID: 25362173 [TBL] [Abstract][Full Text] [Related]
8. Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review. Baines O; Sha R; Kalla M; Holmes AP; Efimov IR; Pavlovic D; O'Shea C Europace; 2024 Feb; 26(2):. PubMed ID: 38227822 [TBL] [Abstract][Full Text] [Related]
9. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes. Bingen BO; Engels MC; Schalij MJ; Jangsangthong W; Neshati Z; Feola I; Ypey DL; Askar SF; Panfilov AV; Pijnappels DA; de Vries AA Cardiovasc Res; 2014 Oct; 104(1):194-205. PubMed ID: 25082848 [TBL] [Abstract][Full Text] [Related]
10. What is cardiac resynchronization therapy? Barold SS Am J Med; 2001 Aug; 111(3):224-32. PubMed ID: 11530034 [TBL] [Abstract][Full Text] [Related]
11. Effect of fiber orientation on propagation: electrical mapping of genetically altered mouse hearts. Punske BB; Taccardi B; Steadman B; Ershler PR; England A; Valencik ML; McDonald JA; Litwin SE J Electrocardiol; 2005 Oct; 38(4 Suppl):40-4. PubMed ID: 16226072 [TBL] [Abstract][Full Text] [Related]
12. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies. Chinitz L; Ritter P; Khelae SK; Iacopino S; Garweg C; Grazia-Bongiorni M; Neuzil P; Johansen JB; Mont L; Gonzalez E; Sagi V; Duray GZ; Clementy N; Sheldon T; Splett V; Stromberg K; Wood N; Steinwender C Heart Rhythm; 2018 Sep; 15(9):1363-1371. PubMed ID: 29758405 [TBL] [Abstract][Full Text] [Related]
13. Cardiac optogenetics: the next frontier. Gruber A; Edri O; Gepstein L Europace; 2018 Dec; 20(12):1910-1918. PubMed ID: 29315402 [TBL] [Abstract][Full Text] [Related]
14. Optogenetic termination of atrial fibrillation in mice. Bruegmann T; Beiert T; Vogt CC; Schrickel JW; Sasse P Cardiovasc Res; 2018 Apr; 114(5):713-723. PubMed ID: 29293898 [TBL] [Abstract][Full Text] [Related]
15. All-optical control of cardiac excitation: combined high-resolution optogenetic actuation and optical mapping. Entcheva E; Bub G J Physiol; 2016 May; 594(9):2503-10. PubMed ID: 26857427 [TBL] [Abstract][Full Text] [Related]
16. Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models. Gruber A; Edri O; Glatstein S; Goldfracht I; Huber I; Arbel G; Gepstein A; Chorna S; Gepstein L J Am Heart Assoc; 2022 Feb; 11(4):e021615. PubMed ID: 35112880 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction. Liu GX; Remme CA; Boukens BJ; Belardinelli L; Rajamani S Heart Rhythm; 2015 May; 12(5):1036-45. PubMed ID: 25623181 [TBL] [Abstract][Full Text] [Related]
18. A GABAergic system in atrioventricular node pacemaker cells controls electrical conduction between the atria and ventricles. Liang D; Zhou L; Zhou H; Zhang F; Fang G; Leng J; Wu Y; Zhang Y; Yang A; Liu Y; Chen YH Cell Res; 2024 Aug; 34(8):556-571. PubMed ID: 38849501 [TBL] [Abstract][Full Text] [Related]